In the middle of Diwali, the government announced an important decision for the people. Drugs for breast and lung cancer will become cheaper. Just before Diwali, such news gave a glimmer of hope to the middle class that they will get better treatment. At the same time, the price of three drugs used in the treatment of cancer will also fall.
The price of these drugs reduced
The government has ordered manufacturers to reduce prices of trastuzumab, osimertinib and durvalumab after exempting them from customs duty and reducing GST. The aim of this measure is to guarantee consumers affordable anti-cancer medicines. Companies must update and report new prices to authorities and dealers. For your information, let us tell you that Trastuzumab is used in the treatment of breast cancer, while Osimertineb is used in lung cancer and Durvalumab is used in both types of cancer.
It was announced in this year’s budget that customs duties would be reduced.
The government, which initiated the reduction of cancer drugs, said that our aim is to provide these essential drugs to the people at low prices. This is why the NPPA has reduced drug prices as much as possible. The GST rate on these drugs has also been reduced. For your information, let us tell you this when presenting the budget in Parliament this year. It was only then that there was talk of reducing customs duties on essential medicines.
New prices implemented from October 10
The government recently announced that the GST rate on medicines has been reduced from 12 percent to 5 percent. This is the reason why its MRP has been reduced from October 10, 2024. Because its new price will be considered effective from the same day.
Disclaimer: Some information in news stories is based on media reports. Before implementing any suggestion, you should consult the relevant expert.
Check out the health tools below –
Calculate your body mass index (BMI)
